Vanda Pharmaceuticals (VNDA) AGM 2026 summary

Opening remarks and agenda

• Meeting commenced at 9:15 A.M. with the CEO presiding and all directors introduced.

• Virtual meeting rules and agenda were made available to participants.

• Participation and discussion limited to official business and stockholders of record.

Board and executive committee updates

• Three directors nominated to serve until the 2029 annual meeting: Richard W. Dugan, Charles C. Duncan, and Anne Sempowski Ward.

Shareholder proposals

• No other nominations or proposals were received in accordance with company bylaws.